Table 4.
Dietary intake in study subjects
| Dietary intake | Reference value | Non-MTX users (n = 32) | MTX users (n = 67) | P valuea |
|---|---|---|---|---|
| Energy, kcal/day | 2,000 | 1,248 (1,158 to 1,507) | 1,249 (1,184 to 1,419) | 0.862 |
| Carbohydrate, g/day | 300 | 183.5 (155.9 to 275.2) | 174.5 (174.2 to 216.9) | 0.994 |
| Percentage of energy | 60% | 58.65% | 55.94% | |
| Protein, g/day | (50) | 51.1 (19.9 to 141.0) | 38.9 (38.3 to 45.8) | 0.849 |
| Percentage of energy | 10% | 16.39% | 12.48% | |
| Fat, g/day | (65) | 43.9 (11.0 to 133.8) | 38.6 (36.2 to 45.0) | 0.505 |
| Percentage of energy | <30% | 31.68% | 27.88% | |
| Cholesterol, mg/day | (<300) | 243.8 (109.4 to 178.4) | 223.6 (77.1 to 516.1) | 0.493 |
Results are expressed as median (95%CI) (n = 99).
aData were compared between methotrexate MTX- and MTX+ subjects by Mann-Whitney U test.